Home › Funds › Spruce Street Capital LP › ENTA

Spruce Street Capital LP position in ENTA

ENANTA PHARMACEUTICALS INC · Health Care

Spruce Street Capital LP reported holding 1,088,731 shares of ENTA (ENANTA PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$14.3M, representing 2.28% of its reported portfolio and ranking #14 among its reported holdings. Spruce Street Capital LP has disclosed ENTA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)1.09M sh
Reported value held$14.35M
Portfolio Weight2.28%
First reportedQ4 2025
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Spruce Street Capital LP's ENTA position evolved

Spruce Street Capital LP first disclosed a stake in ENTA in Q4 2025 at 389,687 shares (US$6.1M). The position peaked in Q2 2026 at 1,088,731 shares, worth US$15.9M. Across 4 filings, Spruce Street Capital LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,088,731 shares valued at US$14.3M. Notable position changes include a 139% increase in Q1 2026 (shares rose 15% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 389.69K $6.15M New
Q1 2026 932.60K $11.78M Add
Q2 2026 1.09M $15.87M Add
Q3 2026 1.09M $14.35M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ENTA and 13F data

ENTA (ENANTA PHARMACEUTICALS INC) is a Health Care company. 27 other funds we track also report a position in ENTA — the largest reported positions include Krensavage Asset Management, LLC (US$41.8M), Farallon Capital Management (US$35.3M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$35.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ENTA

All ENTA fund holders →

FAQ

How long has Spruce Street Capital LP held ENTA?

Spruce Street Capital LP has disclosed ENTA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Spruce Street Capital LP's current position in ENTA?

As of Q3 2026, Spruce Street Capital LP holds 1.09M shares of ENTA (ENANTA PHARMACEUTICALS INC), valued at $14.35M, representing 2.28% of its reported portfolio and ranking #14.

Has Spruce Street Capital LP been buying or selling ENTA?

In the latest 13F filing (Q3 2026), Spruce Street Capital LP held unchanged its position in ENTA. The position peaked in Q2 2026 at 1.09M shares.

Which other funds hold ENTA?

Other major institutional holders of ENTA include Krensavage Asset Management, LLC, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.